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Abstract
Hypothyroid-associated reproductive disorders have
now become a striking phenomenon worldwide but
the molecular mechanism behind these disorders is
not fully known. Pitx2 gene encodes homeodomain
transcription factor, which regulates Plod2 gene in
brain tissue, transactivates gonadotropin genes in
pituitary and plays a substantial role in cell growth
and proliferation in different tissues. Pitx2 binds to
Plod2 promoter and activates this gene in rat ovary.
In this report, we show that Pitx2’s expression is
markedly reduced in hypothyroid ovary as well as in
ovarian granulosa cells, which is recovered with T3-
supplementation both in vitro and in vivo conditions.
Reduced Pitx2 expression could decrease Plod2
expression and hence facilitate ovarian ECM
degradation. We have also observed similar pattern
of expression of Pitx1 and -3 in hypothyroid and T3-
supplemented ovaries. The temporal expression of
Pitx2 across the estrous cycle shows that it is
expressed through all the 4 phases of the cycle and
reaches its maximum in the proestrus phase
suggesting its possible role in ovulation followed by
luteinization. The present study reveals that the
reduced Pitx2 expression in hypothyroid ovary could
lead to ovarian dysfunction by modulating the Pitx2-
Plod2 interaction, further study will be necessary to
unravel the complete regulatory mechanism of Pitx2
in ovarian function.
Introduction
Many structural or functional abnormalities can
impair the production of thyroid hormones and cause the
clinical state termed as hypothyroidism. Hypothyroidism
in the adult animal leads to a number of physiological
disorders as total body metabolism depends on thyroid
hormone. The hypothalamic-pituitary-thyroid axis (HPT)
and the hypothalamic-pituitary-ovarian axis (HPO) are
physiologically related, which act together as a unified
system in a number of pathological conditions [1]. Thyroid
hormone plays vital role in reproduction of both sexes [2-
4]. Female fertility depends upon proper execution of
ovarian development, regulated maturation of oocytes,
proliferation and differentiation of the surrounding somatic
cells [5]. Hypothyroidism associated reproductive
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disorders include irregular oestrous cycle [6-8], ovarian
atrophy [9], disturbed folliculogenesis, absence of corpora
lutea [10], delayed onset of puberty [11], anovulation [12],
amenorrhoea or hypermenorrhoea, menstrual irregularity,
infertility and increased frequency of repeated abortion
[13]. Hypothyroidism impairs reproductive functions in
human beings and in experimental animals, though the
underlying molecular mechanism of this dysfunction is
not clearly known.
T3 receptor has been identified in mammalian ovary
and the role of T3 in steroidogenesis is reported earlier
[14, 15]. In presence of ligand, the TR/co-repressor
complex dissociates and is replaced by a co-activator
complex that can contain histone acetylase followed by
remodelling of chromatin structure and transcriptional
activation [16]. T3 affected genes linked with reproductive
function could correlate hypothyroidism and reproductive
disorders.
In our earlier report, we have shown that Plod
isoforms are down regulated in hypothyroid rat ovarian
granulosa cells with the decreased collagen level in
hypothyroid rat ovaries. These findings convincingly
established that the biosynthesis of major collagens is
reduced in hypothyroid ovary and as a consequence the
ECM formation is severely affected [17-19]. Plod2 gene
encodes procollagen lysyl hydroxylase enzyme that
regulates the hydroxylation of lysine residues in
procollagens, the first step in collagen biosynthesis. The
hydroxylysine residues have two important functions: to
act as attachment sites for carbohydrate units and to
provide stability to intermolecular cross-links. Cross-links
involving hydroxylysine derived aldehydes are more stable
than those involving lysine-derived aldehydes [20]. Plod2
gene is under the target of Pitx2 transcription factor in
mice brain [20]. The proximal promoter region of Plod2
harbors multiple bicoid elements that bind to Pitx2 in
mouse brain [20]. The Pitx isoforms are members of
homeodomain transcription factors, which bind both DNA
and RNA [21-23]. Three members of this family have
been characterized till date, among them Pitx1 and -2 are
expressed in the anterior pituitary [24-26] while Pitx3 is
not [27]. Pitx1 and -2 regulate the genes like LHβ, FSHβ,
GH, PRL and GnRH receptor [28-30] by interacting with
cell-restricted factors such as Steroidogenic Factor1 (SF-
1), Early Growth Response-1 (Egr-1), the heterodimeric
NeuroD1/ Pan1, Tpit and Pit1 [28]. The cell cycle
regulating genes such as cyclin D1 and -D2 are also
controlled by Pitx2, as well as it regulates Wnt dependent
mRNA turn over [31]. Pitx isoforms regulate the
expression of other transcription factors, like Hesx1,
Prop1, Lhx3 and Gata2 [32].
Pitx2 is an upstream activator of Plod2 gene in rat
ovary; moreover induction of Plod2 gene by T3 requires
Pitx2 (our unpublished data). In the present study, we
have shown hypothyroidism severely reduces expression
level of Pitx2 gene and protein and also the T3-mediated
recovery of Pitx2 gene both in in vitro and in vivo
experimental conditions. The similar kind of expression
pattern of other Pitx isoforms namely Pitx1 and -3 have
been shown. Down regulation of Plod2 gene, which in
turn leads to the loss in ovarian structural integrity, could
be due to the reduced Pitx2 expression in hypothyroid
ovary. Moreover we have shown the temporal expression
pattern of Pitx2 in rat ovary across oestrous cycle, which
explores further the role of Pitx2 in ovarian physiology.
Therefore, the altered expression of Pitx2 in ovary due
to hypothyroidism and its binding with Plod2 promoter
evokes pertinent questions regarding its role in
hypothyroidism associated reproductive disorders in
mammals including human beings.
Materials and Methods
Animals and treatment
Animal maintenance was performed as described earlier
[17]. We divided the rats into two groups i.e. 1) euthyroid and
2) hypothyroid. Rats were made hypothyroid by treatment with
propyl thiouracil [PTU, 33]. When the pups were 26 d old, 10
female pups from each hypothyroid and control groups were
injected intraperitoneally with pregnant mare’s serum
gonadotropin (PMSG, Sigma) at a concentration of 10 IU per rat
for each experiment. After 48 h of PMSG injection, i.e. at 28
days of age the female pups were dissected and their ovaries
were collected, pooled followed by RNA and protein isolation
from these tissues. The granulosa cells were isolated from the
ovaries and they were pooled to isolate RNA as well as total
cellular protein as and when required. For T3 and TSH
measurement, serum from 10 individual rats was collected and
the mean value of 10 samples has been shown in table 1.
We strictly followed all details of the animal protocol approved
Table 1. The rats were made hypothyroid as mentioned in the
general materials and methods section. The mean serum T3 and
TSH values in hypothyroid rats and T3-supplemented
hypothyroid rats are shown in the table, above.
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by Institutional Animal Ethics Committee during the
experiments. The rats were given intraperitoneal T3 injection at
a dose of 15µg/ 100 gm body weight [34]. In both control and
hypothyroid sets, the rats were injected from d15 of their birth
for 15 consecutive days, then blood was collected and serum
samples were prepared from each set. Ovaries from each set
were also taken out and total RNA was prepared out of them.
Adult female rats with initial body masses of 200-220 g
were taken to observe their estrous cycle. We determined the
different phases of the estrous cycle from vaginal smears
obtained daily for 2 weeks (two to four cycles) before
experiments. Each phase was characterized by a specific number
and morphology of cells in the vaginal fluid as revealed by
light microscopy. Only animals with a regular estrous cycle
(stages are in sequence and the entire cycle lasts 4-5 days)
were used for the experiments [35]. Intact female rats in different
phases of the estrous cycle were sacrificed to isolate their
ovaries and total RNA was prepared from them.
Granulosa cell and hepatocyte isolation
Ovarian granulosa cells were isolated and utilised for
subsequent experiments according to the methods described
earlier [17]. The granulosa cells were incubated with 100 nM T3
(Sigma) for 4 hours [36] to get the T3-treated control and -
hypothyroid samples. To get the liver and hepatocyte primary
culture, male adult rats (200-250 g) were sacrificed, dissected
and isolation was performed using the standard protocol [37].
The isolated granulosa cells and hepatocytes were more than
90% viable as confirmed by trypan blue dye exclusion test.
Immunofluorescence microscopy
Rat ovarian granulosa cells from control and hypothyroid
rats and also the cells from human skeletal muscle cells (L6)
and cultured rat hepatocytes were fixed on cover glass with
PBS containing 4% paraformaldehyde. The cells were
permeabilized with 0.1 % TritonX-100 in PBS and then incubated
with goat polyclonal anti-Pitx2 antibody (cat# sc-8747, Santa
Cruz Biotechnology, Santa Cruz, CA, dilution 1:50) for 3 h
followed by incubation with FITC-conjugated secondary
antibody (Donkey anti-goat, dilution 1:50, Santa Cruz) for 1 h,
with rigorous washing with PBS in between the above steps. 1
µg/ml 4', 6-Diamidino-2-phenylindole (DAPI), was added in each
set. The stained cells were observed under a fluorescence
microscope (Olympus BX51 microscope, Tokyo, Japan) and
the images were captured with cool snap pro camera (Olympus,
Tokyo, Japan).
RNA isolation
Total RNA was isolated from rat ovary and ovarian
granulosa cells (from control, hypothyroid group, T3-treated
control and hypothyroid rats) using TRI reagent (Sigma)
following the standard protocol [17].
Northern hybridization
Northern blotting and hybridization was performed
following the methods described earlier [38]. Briefly, 10µg of
total ovarian RNA was loaded in each lane of 1% formaldehyde-
agarose gel followed by electrophoresis and transfer to nylon
membrane (Millipore, MA) by capillary transfer method.
Prehybridization was allowed for 2 hours in the buffer
containing 6 X SSC with 50% formamide, 1 X Denhardt’s
solution, 100 µg/ml salmon sperm DNA and 1% SDS at 42°C.
Hybridization was carried out in the same condition with the [α-
32P] dATP-labelled Pitx2 gene fragments for 18 h.Then the
membrane was washed for 90 min at 65°C in 2 X SSC containing
0.1% SDS with subsequent three changes of buffer. The
hybridized membrane was exposed to Kodak X-ray film and
kept at -80°C as per required exposure time. RNA molecular size
markers (0.2 kb-6 kb) used in the test was purchased from MBI
Fermentas (Hanover, MD).
Reverse Transcription-Polymerase Chain Reaction
First strand cDNA synthesis was performed as mentioned
earlier [17, 39]. The PCR was performed with initial denaturation
at 94°C for 5 min and then 35 cycles of denaturation at 94°C for
30 sec, annealing at specific temp. for each set of primers for 45
sec, extension at 72°C for 45 sec, final extension at 72°C for 10
min in the last cycle (Perkin-Elmer 9700, Wellesley, MA, USA).
The RT-PCR products were cloned and sequenced. Since
GAPDH mRNAs are abundant, its amplification reaches the
saturation level after 35 cycles. Therefore, we took out GAPDH
PCR product after 18th cycle and subjected to gel electrophoresis
along with other products. The sequences of the primers used
in semi quantitative RT-PCR along with respective amplicon
sizes and accession numbers of different gene products have
been listed in Table 2.
Table 2. The sequences of the oligonucleotide primers used in semi quantitative RT-PCR along with respective amplicon
sizes and accession numbers of different gene products have been listed in the table, above.
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Real Time quantitative reverse transcription PCR
(QPCR)
The QPCR was performed on iCycler (Bio-Rad
Laboratories, Hercules, CA, USA) machine using DyNAmo
SYBR Green QPCR Kit, (Finnzyme, Finland) following the
manufacturers instructions. In short, 2 µg of total RNA isolated
from ovaries and granulosa cells of control and experimental
rats were reverse transcribed as described above followed by
QPCR. The condition of this QPCR was as follows: initial
denaturation step (95°C for 5 min) and cycling step
[denaturation at 94°C for 15 sec, annealing at specific temp for
each set of primers for 30 sec, extension at 72°C for 30 sec,
repeated for 35 cycles] followed by melt curve analysis (45-
90°C). An internal control GAPDH was amplified in separate
tubes. The CT value was calculated as mentioned below. Data
from three determinations (mean ± SD) are expressed as fold
changes compared to normal rats [40]. The sequence of the
primers used in QPCR along with respective amplicon sizes
and accession numbers of different gene products have been
listed in Table 3.
Western Blotting
The ovaries of control and hypothyroid rats were lysed
in lysis buffer (150 mM NaCl, 500 mM Tris, 10 mM EDTA)
supplemented with protease inhibitors (1µg/ml aprotinin, 1µg/
ml pepstatin, 1µg/ml leupeptin, 1mM PMSF, 1µg/ml trypsin
inhibitor) and 1% Triton X-100. It was then centrifuged at 5,000
rpm for 10 min at 4°C. The supernatant was collected and taking
an aliquot protein concentration was estimated and then
resolved on a 12% sodium dodecyl sulfate polyacrylamide gel
[39] and transferred onto Immobilon-P membranes (Millipore
Corp). 50 µg of total protein from each sample were loaded on
each lane. The membrane was then incubated with 5% blocking
solution (Tris Buffered Saline [TBS] containing 0.1% Tween-
20, 5% non-fat dried milk) for 2 hrs, washed twice with TBS-T
(TBS containing 0.1% Tween-20) and then incubated for 4 hrs
with goat polyclonal anti Pitx2-antibody (cat no# sc-8747, 1:500
dilution), mouse anti-actin antibody (cat no# sc-8432, 1:1000
dilution). The antibodies were purchased from Santa Cruz
Biotechnology and were diluted in 5% blocking solution during
detection. Immunoreactive bands were visualized by reacting
Table 3. The sequence of the oligonucleotide primers used in QPCR along with respective amplicon sizes and accession
numbers of different gene products have been listed in the following table.
alkaline phosphatase-labelled secondary anti goat (1:1000 in
5% blocking solution) and anti mouse antisera (1:2000 dilution)
respectively with the substrate NBT/BCIP [39].
Sequencing and analysis
Sequencing of the plasmid DNA and the PCR products
was performed by ABI Prism Automatic DNA Sequencer (Perkin
Elmer). Sequence alignment and data analysis was done through
BLAST search from NCBI GenBank. [41].
CT value calculation
In QPCR, relative quantification can be done by
comparative CT method. In this method arithmetic formulae are
used to calculate relative expression, compared with a calibrator,
which can for instance be a control (non-treated) sample. The
amount of target normalized to an endogenous housekeeping
gene and relative to the calibrator, is then given by 2-ΔΔCT, where
ΔΔ CT=Δ CT (sample) - Δ CT (calibrator), and Δ CT is the CT of
target gene subtracted from the CT of the housekeeping gene
[40].
Statistical analysis
All data are expressed as the mean ± SD, and statistical
analysis was performed by Student’s t-test. P<0.05 was
considered to be significant. The experiments were repeated at
least three times in duplicate unless otherwise stated. To make
the variance independent of the mean, statistical analysis of
real-time PCR data was performed after logarithmic
transformation.
Results
Pitx2 expression is decreased in hypothyroid
condition
Experiments were performed to find out whether
the expression level of Pitx2 gene is affected in
hypothyroid condition. The results show a significant
decrease in the Pitx2 expression level in hypothyroid
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(a) (b)
(c)
(d)
Fig. 1. Expression of Pitx2 in control and hypothyroid rat ovaries. Ovarian RNAs from control (C) and hypothyroid (H) rats were
isolated and were subjected to RT-PCR and QPCR using gene specific primers of Pitx2 and GAPDH. The RT-PCR products are
shown in (a) and the fold difference in QPCR has been shown in (b). In Fig.a the amplified product sizes are indicated with arrows.
The isolated RNAs were electrophoresed on agarose gel and Northern hybridized with radio-labeled Pitx2 cDNA fragment as
probe. Fig (c) shows the hybridized band and the ethidium bromide stained rRNA bands have been shown as loading control.
Total proteins isolated from control and hypothyroid rat ovaries were immunodetected with goat polyclonal anti-Pitx2 antibody
(d), which was normalized over the expression of actin (here mouse monoclonal actin antibody was used). The molecular weights
of the respective proteins have been indicated with arrow. In Fig 1a-d, C and H represent the samples isolated from control and
hypothyroid rats respectively. Below the panel of Fig 1a and d, scanning data of the respective band intensities have been
shown, where pixel value of each band was calculated by the ImageJ software. The above experiments were performed three times
in duplicate and the scanning data is the mean ± SD. *P < 0.05.
condition compared to control as shown by RT-PCR (Fig
1a), QPCR (Fig 1b) and Northern hybridisation (Fig 1c).
Western immunoblotting was conducted to find out
whether the change in Pitx2 gene expression is reflected
in its protein level or not. Ovarian proteins of control and
hypothyroid rats were isolated and subjected to SDS-
PAGE followed by transfer onto the PVDF membrane
and western immunodetection. Western immunoblot with
anti-Pitx2 antibody showed a marked decrease of Pitx2
under hypothyroid condition compared to control (d),
whereas expression of actin remained unaltered (here
the expression of Pitx2 is normalized over that of actin).
The same experiment was performed with the proteins
isolated from ovarian granulosa cells and the Pitx2 protein
significantly decreased in the hypothyroid condition
compared with control (data not shown).
Localization of Pitx2 in ovarian granulosa cell
To localize the Pitx2 protein in the ovarian granulosa
cells, immunocytochemistry was performed with anti-
Pitx2 antibody followed by FITC-tagged secondary
antibody. The data confirms the presence of Pitx2 in the
nucleus of ovarian granulosa cells isolated from the control
rat (Fig 2a). The intensity of the fluorescence in granulosa
Hypothyroidism affects Pitx2 expression in ovary Cell Physiol Biochem 2007;20:887-898
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cells isolated from the hypothyroid rats (Fig. 2c) was
significantly less compared to that in control set, which
gives a clear indication of less expression of Pitx2 in
hypothyroidism. Pitx2 is known to express in skeletal
muscle, whereas in hepatocytes it does not. Therefore,
these two cells were chosen as positive and negative
control respectively in our experiment. The data shows
the presence of Pitx2 in the nucleus of L6 cells when
incubated with Pitx2 Ab (Fig 2e). However, no
fluorescence was detected in hepatocyte in presence of
Pitx2 Ab (Fig 2g) confirming the specificity of the signals
obtained. The DAPI stained cells corresponding to Fig
2a, c, e and g are represented as 2b, d, f and h respectively.
Fig. 2. Cellular distribution of Pitx2 in the rat
ovarian granulosa cells. Immunocytochemistry
was performed with the granulosa cells isolated
from control and hypothyroid rat ovaries, using
Pitx2 antibody and FITC linked secondary
antibody and the cells from each set were also
stained with DNA-specific dye, i.e. DAPI.
Similarly immunocytochemistry was also
performed in L6 cell line (human skeletal
muscle) and in rat hepatocytes. The granulosa
cells isolated from euthyroid rat ovaries were
treated with Pitx2 antibody (a) and the cells
from hypothyroid animals were treated with
Pitx2 antibody (c). However, L6 cells were
treated with Pitx2 Ab (e) and hepatocytes were
treated with (g) Pitx2 Ab; each set was then
treated with FITC-linked secondary antibody.
The respective DAPI stained cells have been
shown as ‘b’ (control granulosa cells), ‘d’
(hypothyroid granulosa cells), ‘f’ (L6 cells), and
‘h’ (hepatocytes).
In vitro and in vivo effect of T3 on Pitx2 gene
expression
The significant decrease in Pitx2 expression in
hypothyroidism suggests a definite role of T3 in regulating
the expression of this gene. To show the in vitro effect
of T3 on Pitx2 gene expression, ovarian granulosa cells
were isolated from control and hypothyroid rats, incubated
in presence or in absence of T3 as described in the
methods section. RNA was isolated from the ovarian
granulosa cells and RT-PCR as well as QPCR was
performed with the gene specific primers of both Pitx2
and GAPDH. The results of RT-PCR (Fig 3a) and QPCR
(Fig. 3b) show that Pitx2 gene expression was significantly
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Fig. 3. In vitro and in vivo effect of T3 on Pitx2 expression. RNAs were isolated from control (C), hypothyroid (H), T3-treated
control (CT) and T3-treated hypothyroid (HT) ovarian granulosa cells to observe in vitro effect of T3 on Pitx2 gene expression.
Using these RNAs, RT-PCR was performed with the gene specific primers of Pitx2 (Fig. a) and the respective product sizes are
indicated with arrow. The QPCR was performed using the gene specific primers of Pitx2 and GAPDH and represented in Fig b. The
expression level of Pitx2 is normalized over that of the GAPDH and the comparative expression is indicated as change in ‘fold’ in
the Y-axis. Similarly, for in vivo studies, RT-PCR was performed with the gene specific primers of Pitx2 (Fig. c) and the respective
product sizes are indicated with arrow. QPCR was also performed with gene specific primers of Pitx2 and GAPDH and the
expression level of Pitx2 is normalized over that of the GAPDH and the comparative expression is indicated as change in ‘fold’ in
the Y-axis (Fig. d). In Fig ‘a’ and ‘c’, the expression of Pitx2 has been normalized with that of GAPDH gene expression. The scan
data of the bands obtained as pixel value using the Image J software are shown as a bar diagram below the results of RT-PCR (Fig
a and c). The above experiments (a-d) were performed three times in duplicate and the scanning data is the mean ± SD, *P < 0.05.
decreased in hypothyroid condition compared to control,
whereas its expression was increased to a significant
extent upon T3 addition in the culture medium of control
granulosa cells. However, the reduction in expression of
Pitx2 due to hypothyroidism was restored upon addition
of T3 in the granulosa cell culture medium isolated from
the hypothyroid rat ovaries. This suggests that T3 has an
influential role on Pitx2 gene expression in in vitro cell
culture system.
To obtain the in vivo effect of T3 on Pitx2 gene
expression, the rats were injected with T3 as described in
methods section. Similar to the in vitro effect, Pitx2 gene
expression was increased in T3-injected control and -
hypothyroid ovaries compared to that in the ovaries of
control and hypothyroid rats respectively as shown by
RT-PCR (Fig 3c) and QPCR data (Fig 3d). The expression
of Pitx2 both in vivo and in vitro as obtained by RT-
PCR has been normalized by GAPDH gene expression.
Pitx2 expression pattern in rat ovary across
oestrous cycle
Both RT-PCR and QPCR were performed with total
RNA isolated from different stages of rat ovaries across
the oestrous cycle. Both RT-PCR (Fig. 4a) and QPCR
(a)
(c)
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(Fig. 4b) data show similar expression pattern of Pitx2 in
metestrus and diestrus stages. In proestrus stage, Pitx2
expression level was significantly higher compared to
metestrus and diestrus stages, whereas at the oestrous
stage its expression was reduced to the normal level (lane
4). The expression of Pitx2 has been normalized over
GAPDH gene expression and presented in Fig. 4a. The
QPCR data (Fig. 4b) shows the similar pattern of Pitx2
expression level across the stages of oestrous cycle as
was obtained in the RT-PCR result. The above data shows
Fig. 4. Pitx2 expression pattern in rat ovary across the estrous
cycle. Both RT-PCR (Fig. a) and QPCR (Fig. b) were performed
with total RNA isolated from rat ovaries across oestrous cycle.
Fig. (a) shows Pitx2 expression level at metestrus (lane 1),
diestrus (lane 2), proestrus (lane 3) and at oestrous (lane 4)
stages respectively. The expression of Pitx2 has been normalized
with that of GAPDH and shown in the figure. In Fig. a, respective
product sizes are indicated with arrow and below the panel,
scanning data of the respective band intensities have been
shown, where pixel value of each band was calculated by the
ImageJ software. Fig. (b) shows the QPCR data where
expression pattern of Pitx2 has been shown in the same order
as mentioned in Fig. (a). In QPCR, the expression level of Pitx2
is normalized over that of the GAPDH and the comparative
expression is indicated as change in ‘fold’ in the Y-axis. The
experiments were performed three times in duplicate and the
scanning data is the mean ± SD, *P < 0.05.
Fig. 5. Pitx1 and -3 are present in rat ovary and the effect of T3
over their expression. QPCR was performed using RNAs isolated
from control (C), hypothyroid (H), T3-incubated control (CT)
and from T3-incubated hypothyroid (HT) ovarian granulosa
cells. QPCR result with Pitx1 and Pitx3 gene specific primers is
shown in Fig a and Fig b respectively. In QPCR the expression
level of Pitx1 and -3 are normalized over that of the GAPDH and
the comparative expression is indicated as change in ‘fold’ in
the Y-axis. The sequences of the primers used for Pitx1 and -3
amplification, have been mentioned in materials and methods
section. The experiments were performed three times in duplicate
and the scanning data is the mean ± SD, *P < 0.05.
the temporal expression pattern of Pitx2 in ovary across
estrous cycle.
Effect of T3 on Pitx1 and -3 expressions
Oligonucleotide primers for Pitx1 and -3 were
synthesised (as mentioned in methods section) to perform
QPCR using total RNA isolated from control, hypothyroid,
T3-incubated control and -hypothyroid rat ovarian
granulosa cells respectively. QPCR data shows that like
Pitx2, Pitx1 (Fig 5a) and -3 (Fig. 5b) isoforms were
(a)
(b)
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Fig. 6. Schematic representation of a
hypothetical model to show the possible
involvement of Pitx2 in disintegration of
ovarian ECM and subsequent ovarian
dysfunction in hypothyroid condition.
In this scheme, upward arrows indicate
up regulation of gene or protein
expression and downward arrows
indicate down regulation of the same.
markedly reduced in hypothyroid condition compared to
control. Their expression levels were significantly
increased in T3-incubated control and -hypothyroid ovarian
granulosa cells. This data suggests that like Pitx2, Pitx1
and -3 expressions are also affected by T3.
Discussion
Thyroid dysfunction is very common in women and
has unique consequences related to menstrual cyclicity
and reproduction. Even mild hypothyroidism can increase
rates of miscarriage and fetal death and may also have
adverse effects on later cognitive development of the
offspring [42]. Thyroid function and reproductive function
have many interactions, the mechanism of which is not
fully understood [43]. A wide range of reproductive
disorders such as irregular menstruation and frank
infertility is found in women with hypothyroidism. Most
of the research work done so far has focused on steroid
and gonadotropin hormone profiles [44]. However, its
cause and the molecular basis of the pathophysiological
mechanism are yet to be ascertained. Several transcription
factors have already been reported to play crucial role in
regulating significant genes, whose mutant forms may
cause impaired follicular growth and differentiation,
immature oocyte formation, meiotic arrest of oocytes,
ovulatory problem and also impaired steroidogenesis [45,
46]. In an endeavor to find out the molecular basis of
hypothyroidism associated ovarian dysfunction, we
performed several experiments in hypothyroid rat model.
The serum T3 and TSH levels were measured in
hypothyroid and T3-supplemented rats, which showed that
the rats were truly hypothyroid.
Ovary is a very dynamic organ where follicles and
corpora lutea continually grow and regress and ovarian
ECM is extremely important for the follicular development,
helps follicular fluid formation, filters soluble materials;
provides rigid or elastic mechanical support for tissues
[47]. Collagen biosynthesis requires a large number of
post-translational modifications. One of the important steps
in collagen biosynthesis is hydroxylation of lysine residues,
which provide attachment sites for glycosylated
hydroxylysine residues. Plod2 gene encodes procollagen
lysyl hydroxylase enzyme that regulates the hydroxylation
of lysine residues in procollagens, the first step in collagen
biosynthesis.
 Pitx2 is an upstream activator of Plod2 gene in brain
tissue [20] and in ovary (our unpublished result). In this
report we show that Pitx2 is down regulated in hypothyroid
ovary, supported by RT-PCR, QPCR, Northern
hybridization, immunocytochemistry and immunoblotting
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data. Therefore, we postulate that the reduced expression
of Pitx2 may be responsible for the down-regulation of
Plod2 gene in hypothyroid ovary. Both in vitro (in ovarian
granulosa cells) and in vivo (in ovary) studies suggest
that T3 has definite role in Pitx2 gene expression. T3 up
regulates Pitx2 gene expression in normal rat ovary and
T3 supplementation recovers its reduced expression in
total ovary. Since Pitx1 and -2 share binding specificities
to transactivate their target genes [28], we do not exclude
the possibility that these isoforms might also be involved
in the regulation of Plod2 gene. In vitro studies show like
Pitx2, similar type of influence of T3 on Pitx1 and -3
expressions was found in ovarian granulosa cells. Since
hypothyroidism reduces the expression of all Pitx
isoforms, the chance of rescuing Plod2 expression by other
isoforms seems to be very less. However, the target genes
of Pitx1 and -3 in ovary and their regulatory pathways
could be studied in future. It is noteworthy that Rieger
syndrome causing Pitx2 mutant failed to induce Plod2
gene [20]. It is compatible with our hypothesis that
suggests, down regulation of Pitx2 affects Plod2 gene
expression. However, in αSUnul mice, the expression of
Pitx2 was unaltered when treated with T4 [48] in pituitary
tumor. We propose that the T3-influenced altered
expression of Pitx2 in ovary could be due to the tissue-
specific regulation of thyroid hormone.
 The temporal expression pattern of Pitx2 in rat ovary
across estrous cycle suggests that it could play role in the
follicular development as Pitx2 is remarkably increased
in proestrus phase compared to other phases. In the
proestrus phase, when the progesterone level is low [49]
and the specific follicles destined to ovulate among others,
Pitx2 expression is the maximum. In the estrus phase,
when ovulation occurs and estrogen level reaches at its
maximum [49], Pitx2 expression is remarkably less. In
the metestrus and diestrus phases, when estrogen level
is less and progesterone levels begin to rise and the
corpora lutea predominates, Pitx2 expression is maintained
at the low level. This suggests that Pitx2 expression
across the estrous cycle is modulated by steroid hormones.
In in vitro studies with human ovarian cell line (SK-OV3),
we have found altered expression of Pitx2, which was
decreased in the higher dose of estrogen supplementation
in the culture medium (data not shown). This result is
compatible to the in vivo effect of estrogen in ovarian
Pitx2 gene expression as already discussed here. There
may be other factor(s) regulating the expression of
Pitx2 in ovary and further study will unravel these
regulatory mechanisms.
The possible involvement of Pitx2 in regulation of
Plod2 gene expression and the consequent ECM
disintegration in hypothyroid ovary has been schematically
represented in a hypothetical model (Fig 6). In this
schematic representation, the association of Pitx2 with
its cofactor Pit1 (our unpublished data) has also been
implicated in regulation of ovarian function. Pitx2 may
regulate so far unidentified genes, apart from Plod2, in
ovary and that may affect steroidogenesis, ovarian
development and folliculogenesis in hypothyroid condition.
Pitx2 is necessary for initiating expansion of Rathke’s
pouch and maintaining expression of the foetus-specific
transcription factors, like Hesx1 and Prop1 [50]. At later
stages Pitx2 is necessary for specification and expansion
of the gonadotropes. Thus the reduced Pitx2 in
hypothyroid ovary not only facilitate disintegration of
ovarian structure but also could impair ovarian growth
and its functions and there is enough scope of further
extensive studies in this specific area.
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